(Q41827081)

English

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

scientific article published on September 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system (English)

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

0 references

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

author name string

Culig Z

1

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Hoffmann J

2

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Erdel M

3

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Eder IE

4

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Hobisch A

5

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Hittmair A

6

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Bartsch G

7

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Utermann G

8

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Schneider MR

9

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Parczyk K

10

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

Klocker H

11

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

81

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

2

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

242-251

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

describes a project that uses

0 references

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

BAG-1L protein enhances androgen receptor function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Analysis of growth factor and receptor mRNA levels during development of the rat seminal vesicle and prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Androgen-repressed phenotype in human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Activation of androgen receptor in epidermal growth factor modulation of fetal mouse sexual differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Activation of the human androgen receptor through a protein kinase A signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

LNCaP model of human prostatic carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Enzymatic synthesis of biotin-labeled polynucleotides: novel nucleic acid affinity probes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Androgen receptor gene expression in human prostate carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Androgen receptors in endocrine-therapy-resistant human prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Isolation of a human prostate carcinoma cell line (DU 145)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Establishment and characterization of a human prostatic carcinoma cell line (PC-3)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

6 June 2018

Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

18 August 2018

Distant metastases from prostatic carcinoma express androgen receptor protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362859

18 August 2018

A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen receptor status of lymph node metastases from prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiandrogen withdrawal syndrome in relapsed prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10496349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690684

7 January 2021

based on heuristic

inferred from DOI database lookup

Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690684

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6690684

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41827081&oldid=2204785593"